Stocks to sell

Apple’s (NASDQ:AAPL) first-quarter financial results contained some very discouraging signs, making the stock a sell in the near-term. Up until now, it has been easy to defend Apple stock. Sales of the company’s electronic devices — its iPhones and MacBooks — had been slowing, but the services side of the business — streaming and Apple

Earnings season is drawing to a close, with more than 90% of stocks in the S&P 500 index having reported their first-quarter financial results. However, some big names still need to issue their Q1 prints. For a few of these companies, the stakes are high. Analysts and investors will be scrutinizing the data for signs

Morgan Stanley (NYSE:MS) strategists are urging investors to snap up U.S. government bonds, even if the economy doesn’t slow down. They believe bond yields could fall dramatically driven by “residual seasonality,” a statistical quirk that can sway economic data even after seasonal adjustments. This could lead to predicting a more rapid decline in inflation than

Murmurs of a potential hard economic landing are resurfacing after a marked downturn in U.S. GDP during the first-quarter (Q1).  The U.S. economy slowed sharply in Q1, growing at just 1.6%, lagging significantly behind the 2.5% estimate. Moreover, a soft jobs report compounds those concerns further. Hence, it’s probably the right time to consider consumer

Dividend Aristocrats are a unique class of dividend stocks. They are companies that are members of the S&P 500 and have increased their payouts to shareholders for at least 25 years. That’s no small feat. Out of the thousands of publicly traded stocks on the market, only 68 stocks made the cut this year.  This

While it’s not dominating the news cycle like it did during the meme stock craze of 2021, the Reddit (NYSE:RDDT) message board r/WallStreetBets is still going strong. The sub-Reddit is still a main gathering place for retail investors to discuss, debate and dissect stocks and share ideas. Many of the comments, memes, and videos posted

Adam Aron, the CEO of global movie-theater chain AMC Entertainment (NYSE:AMC), is a great cheerleader for the company. However, even Aron had to acknowledge a problem that impacted AMC Entertainment’s financial figures this year. As the company continues to bear the weight of massive debt, it’s wise to avoid AMC stock in 2024.          

Keeping an eye on what Barclays and other large investment banking firms can provide insights into a stock’s market position. These price targets, like any other financial analysis, are predictions that cannot account for the human factors of a corporation, such as quality control, leadership, and productivity. Looking for stocks with lowered price targets helps

The cruise industry has long been a popular choice for travelers seeking a unique and luxurious vacation experience. However, behind the glitz and glamor, the industry has been grappling with several inherent weaknesses. Those have left the sector particularly vulnerable to economic downturns and unforeseen crises. These susceptibilities have been brought to the forefront in

Lucid Group (NASDAQ:LCID) hasn’t re-hit all-time lows just yet, but give it time. Lucid stock should decrease in price based on its latest results and guidance updates. The issues of weak demand, cash burn, and shareholder dilution persist. Lucid may not be on the verge of experiencing a “game over” moment in the near-term, yet

The S&P 500 has delivered impressive returns over the past year, especially in 2023, when tech stocks soared, leading the index to a remarkable 25% gain. However, not all stocks within the S&P 500 are positioned for continued success. Some of these S&P 500 stocks to sell are overvalued or face looming challenges. Macroeconomic factors

The stock market has trended higher over the last month as this has proven to be one of the best earnings seasons in years. With over three-quarters of companies having now reported, earnings have grown around 5% in the last quarter. As one of the biggest gains since the pandemic and beats analysts’ expectations, it

When high-flying stocks plunge by 50% or more, there is always a temptation to consider exposure at oversold levels. There are cases of a strong rally after a big sell-off on the back of a short-squeeze or improvement in company fundamentals. However, it’s not necessarily true in all cases of big corrections. This overview is

Many investors agree that it’s wise to “sell in May and go away.” This age-old Wall Street adage stems from the observation that stock market returns tend to be weaker during the summer months (May through October) compared to the winter months (November through April). This phenomenon is sometimes referred to as the “Halloween indicator” or the “sell in May

I’d like to begin this article by informing you that I am personally opposed to the overall concept of a metaverse. My bias against it stems from the belief that, as a project, it lacks the substance necessary to deliver on its financial promises. After all, for it to succeed, the quality of life in virtual reality would have

With Advanced Micro Devices‘ (NASDAQ:AMD) competition getting steeper on multiple fronts and the valuation of AMD stock rather elevated, I recommend selling the shares at this point. Also likely to weigh on the stock going forward are China’s harsh restrictions on the use of its chips. Finally, there are multiple signs that the Street is

Intel (NASDAQ:INTC) stock continues to decline, making it the worst performer in the S&P 500 index this year. Since January, INTC stock has fallen nearly 40%, placing it at the bottom of 503 companies listed in the benchmark S&P index. Today, the share price of Intel is 35% lower than where it was in 2019.

Whether you’re a staunch environmentalist or an electric vehicle enthusiast, the current state of the lithium industry is concerning. That’s because the lithium commodity’s dreadful impact on landscapes and its lackluster performance. For investors, lithium was not always the most exciting play, after all, it supported the steady smartphone and rechargeable battery industry. Yet, in

Although 5% up over one year, the S&P Biotechnology Select Industry Index is down .22% year-to-date. This seems to be a normalization period. Following the investment splurge during the viral scare, the biotech sector experienced the proverbial renaissance. In this context, identifying biotech stocks to sell is essential, as some may falter despite the sector’s

There are several stocks to sell now that are clinging to life support. These companies have been diluting their shares and burning cash at an alarming rate, making a successful comeback an increasingly unlikely prospect. Rather than accepting reality, management has resorted to desperate measures to keep the lights on, effectively kicking the can down